Biotechnology - , ,
Kinagen is a drug discovery and development company, positioned to establish a new class of drugs that stabilize kinases in an inactive state.The Company has established the Kinagen Platform and a pipeline of differentiated product opportunities with efficacy and safety advantages that promise to deliver improved treatments for patients.Kinagen's RAF Blockade drug candidate has been shown to directly address the limitations of other approaches and promises to provide durable benefits to a broad range of cancer patients.